Submitted by Anonymous (not verified) on 7 November 2025 - 14:19
Orphan designation: Obinutuzumab Treatment of follicular lymphoma, 19/06/2015 Withdrawn
Source:
Orphan designation: Obinutuzumab Treatment of follicular lymphoma, 19/06/2015 Withdrawn